P. Mene et al., EICOSANOID SYNTHESIS IN PERIPHERAL-BLOOD MONOCYTES - A MARKER OF DISEASE-ACTIVITY IN LUPUS NEPHRITIS, American journal of kidney diseases, 32(5), 1998, pp. 778-784
A typical feature of lupus nephritis is glomerular and interstitial le
ukocyte infiltration. In search of a serological marker of renal disea
se activity, we examined prostaglandin endoperoxide synthetase (PGHS)
activity in peripheral-blood monocytes isolated from 5 healthy subject
s and 11 untreated patients with biopsy-proven lupus nephritis, using
radioimmunoassay of prostaglandin E-2 (PGE(2)) and thromboxane B-2 (Tx
B(2)) released during 24-hour cultures with selective stimuli/inhibito
rs. Unstimulated basal PGE(2) and TxB(2) synthesis, reflecting in vivo
PGHS activity, was greater in the five patients with active renal inv
olvement (World Health Organization [WHO] classes IVb-c) and the six l
upus patients without active disease than in the five healthy subjects
(TxB(2), 2,643 +/- 198 [standard error], 2,015 +/- 190, 1,548 +/- 295
pg/10(6) cells, respectively). Escherichia coli lipopolysaccharide (L
PS; 10 mu g/mL) potently induced TxB(2) or PGE(2) synthesis in healthy
controls (+255% +/- 76% and +611% +/- 190%, +688% +/- 234% and +3,189
% +/- 154%; 4 to 24 hours, respectively), an effect abolished by 5 mu
mol/L of dexamethasone (DEX) or by 5 mu mol/L of the protein synthesis
inhibitor cycloheximide (CHX). Responses to LPS were reduced in lupus
patients without disease activity and reduced even further in those w
ith active nephritis. This may be related to substrate depletion or fe
edback functional inhibition of the inducible isoform of PGHS. Our ass
ay may prove useful in the early detection of kidney disease activity
in lupus erythematosus. (C) 1998 by the National Kidney Foundation, In
c.